Diabetes is a complex metabolic disease that affects multiple organ systems in the body. Diabetes-induced complications in the kidneys, eyes, cardiovascular and peripheral nervous system have been well established. Diabetes-related complications in the central nervous system (CNS) are now being increasingly recognized and investigated.
regression analyses showed that the diagnosis of polyneuropathy was best predictor of performance on cognitive testing. Severe recurrent hypoglycemia was not found to be associated with cognitive dysfunction in this study. 2 The age of diabetes onset appears to be an important variable in predicting cognitive dysfunction in children with type 1 diabetes. In a meta-analysis, Gaudieri et al. examined a sample of 2,144 children consisting of 1,393 study subjects with type 1 diabetes and 751 control subjects from 19 studies and found that cognitive changes were most pronounced for children with early-onset diabetes.
9 These children had slightly lower overall cognition with mild differences in learning, memory, attention and executive function skills compared to healthy controls.
Perantie et al. studied the effects of hypoglycemia on cognitive function in youth (in children aged five to 16 years). They found the greatest deficits in spatial intelligence and delayed recall in those children who experienced severe hypoglycemic episodes before the age of five years. 4 These observations suggest that the developing brain may be particularly vulnerable to the effects of extremes in glycemia.
Type 2 Diabetes
Several large population-based studies have shown patients with type 2 diabetes have a significantly increased risk of developing both mild cognitive impairment, which is believed to be a predictor of Alzheimer's disease, and dementia when compared to controls without diabetes. [10] [11] [12] [13] This increased risk pertains to both Alzheimer's and vascular-type dementias. 10, 14 In a prospective, population-based study of more than 6,000 subjects, the presence of diabetes mellitus almost doubled the risk of dementia.
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In the Epidemiology of Vascular Aging study of community-dwelling elders with normal cognition at outset, only those subjects with diabetes showed deterioration in cognitive function over the four years of follow up. 11 While insulin use has been associated with the highest risk for dementia in some studies, 10 just the presence of the disease appears to greatly increase dementia risk in patients with type 2 diabetes.
The degree of chronic hyperglycemia may be an important determinant in the cognitive dysfunction seen in subjects with type 2 diabetes. The
Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) study included nearly 3,000 subjects. A strong inverse relationship was identified in this study between glycated hemoglobin (HbA 1c ) and cognitive performance in the areas of:
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• visual motor function;
• attention;
• learning;
• working and verbal memory; and
• executive function. In this cohort, more severe cognitive dysfunction was associated with an even greater risk of cardiovascular events. These subjects were also at increased risk of severe hypoglycemia. Figure 1 ). In patients with type 2 diabetes these white matter changes have been associated with reduced performance on tests of attention, executive function, information processing speed and memory.
37,38
In a population-based study of elderly patients without dementia, type 2 diabetes was associated with hippocampal and amygdala atrophy on MRI compared to control subjects. This association did not change after adjusting for blood pressure and vascular disease. 39 The hippocampus has high density of insulin receptors 40 and its role in memory formation makes it an area of great interest in diabetes.
Interestingly, hippocampal and amygdala atrophy are also seen in Alzheimer's disease.
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In a recent study, Yau et al. 42 demonstrated that obese adolescents with type 2 diabetes had reduced whole brain volume, particularly in the frontal lobe. They also had diffuse reduced white and grey matter microstructural integrity on diffusion tensor imaging compared to controls. These adolescents with type 2 diabetes demonstrated significantly reduced cognitive performance in areas of intellectual functioning, verbal memory and psychomotor efficiency. 42 Given the youth of these subjects and the relatively short duration of diabetes, it is likely that these structural and cognitive changes are mediated by factors other than atherosclerotic vascular disease.
In a resting-state functional MRI study of elderly subjects with type 2 diabetes, Zhou et al. recently found that the hippocampus showed reduced functional connectivity bilaterally to widespread regions compared to healthy controls. 43 It was found that the regions with reduced connectivity included:
• fusiform gyrus;
• frontal gyrus;
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Figure 1: An Example of Subcortical (A) and Periventricular (B) White Matter Hyperintesities on Brain Magnetic Resonance Imaging
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• temporal gyrus;
• anterior cingulate gyrus;
• medial frontal gyrus;
• posterior cingulate gyrus; and
• precuneus and inferior parietal lobule.
These findings suggest that type 2 diabetes is associated with an impaired pattern of default network function that may be involved in the pathophysiology of cognitive dysfunction.
Potential Mechanisms for Diabetes-related Changes in Cognition and Cerebral Structure
The pathophysiology underlying the cognitive dysfunction and changes in cerebral structure in patients with diabetes are not completely understood. Several possible mechanisms have been postulated, including the roles of hyperglycemia, insulin resistance and vascular disease. It is likely that further research will reveal that, rather than a single cause, the underlying mechanism of cognitive dysfunction involves a combination of these factors.
Hyperglycemia
Poor glycemic control is associated with cognitive dysfunction in both type 1 and type 2 diabetes. Improving glycemic control in patients with type 2 diabetes has been shown to reduce cognitive dysfunction.
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In other organs, the effects of chronic hyperglycemia are mediated through several pathways. These include:
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• the increased formation of advanced glycation end-products;
• polyol pathway activation;
• diacylglycerol activation of protein kinase C; and
• increased glucose shunting in the hexosamine pathway.
The same mechanisms may be involved in the cerebral complications seen in patients with diabetes.
Hyperglycemia has also been proposed to cause end-organ damage through increases in reactive oxygen species. In a cross-sectional study of young people with type 1 diabetes, Dominguez et al. 45 found markers of systemic oxidative stress to be present at the time of diagnosis of the disease. These markers were significantly increased compared to controls. Interestingly, the levels of these markers continued to rise over the course of disease, suggesting prolonged exposure to oxidative stress in patients with type 1 diabetes.
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In addition, hyperglycemia raises serum osmolality, which in turn has downstream effects on cerebral metabolism. Chronic hyperglycemia is associated with a chronically high demand for vasopressin. This has been shown to lead to several molecular changes within the vasopressin-producing hypothalamic neurons that may contribute to degeneration of these neurons in diabetic rats.
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In human patients with poorly controlled type 1 diabetes, the myoinositol content in the basal ganglia was found to be elevated compared to controls using magnetic resonance spectroscopy.
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Myoinositol level was also noted to be high in another study of patients recovering from diabetic ketoacidosis. 47 Myoinositol is a marker of changes in osmolarity. Increased levels of this marker have been associated with both gliosis and demyelination.
48
Vascular Disease
As discussed above, type 2 diabetes has been associated with an increased risk for both Alzheimer's and vascular-type dementias.
Vascular disease has been postulated to be a critical factor contributing to the functional and structural changes seen in the brains of subjects with diabetes.
In a study by Manschot et al., macrovascular atherosclerotic disease appeared to be the most consistent determinant of impaired cognition and brain MRI abnormalities in type 2 diabetes patients. 37 In type 1 diabetes, the occurrence of microvascular disease has been associated with reduced cognitive function. 8 Thickening of capillary basement membrane, which is a distinctive feature of microangiopathy, has been seen in brains of patients with diabetes.
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In the Age Gene/Environment Susceptibility-Reykjavik Study, which is a large community-based cohort of older individuals, signs of retinal arteriolar changes, such as arteriovenoius nicking, microaneuryms and hemorrhages, were associated with the presence of multiple microbleeds in the brain. 50 These associations were stronger in subjects with diabetes than in healthy controls and were independent of potential confounders like high blood pressure, ischemic brain lesions and other vascular lesions. These observations suggest that there may be a diabetes-specific mechanism that contributes to microvascular changes in both the retina and brain.
Insulin and Insulin Resistance
A growing body of literature suggests that defects in cerebral insulin action may be linked to cognitive dysfunction. 51, 52 Insulin receptors have been found to be widely distributed in the human brain, with higher concentrations located in the hypothalamus, cerebellum and cortex. Insulin resistance may also be associated with hypercortisolemia, which has been linked with cognitive dysfunction. 58, 59 In some studies, subjects with type 2 diabetes have been found to have upregulation of the hypothalamic-pituitary-adrenal axis, with increased serum cortisol 
Future Directions
From the current evidence, it is clear that patients with both type 1 and type 2 diabetes have abnormalities in neurocognitive function and cerebral structure. The impact of these changes on the life of the patient generally appears to be subtle, but may be clinically significant in some individuals.
The number of patients with diabetes who experience the CNS complications of the disease may grow as the life expectancy of patients with diabetes is extended with better therapies. Consequently, future research must focus on more precisely identifying the natural history of the CNS complications of diabetes. Prospective studies will help identify the prevalence of this complication and determine the impact of age, diabetes duration and other clinical characteristics on the development of specific changes in brain structure and function.
In addition to this, future research needs to examine the mechanisms responsible for the development of changes in brain function and structure in diabetes. Hyperglycemia-and hypoglycemia-induced end-organ damage seem to play an important role. The presence of comorbidities, such as hypertension, and aging may also exacerbate the metabolic effects of hyperglycemia on the brain.
The biochemical pathways altered in the brain by exposure to diabetes and the specific cells affected by such exposure must be the topic of future research. Until it is understand how diabetes affects the brain on the molecular level, effective strategies to prevent and treat the cerebral complications of diabetes cannot be developed.
Conclusion
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